AETC National Coordinating Resource Center

The AETC National Coordinating Resource Center provides education, training, and capacity building resources for the AETC Program to support the mission to offer timely, high quality, state-of-the-science information to healthcare professionals working with existing and emerging populations affected by HIV.

Andrea Norberg, DNP, MS, RN

Principal Investigator

[email protected]

Phone: (973) 972-5141

Fax: (973) 972-0397

John Nelson, PhD, CNS, CPNP

Program Director

[email protected]

Phone: (973) 972-6268

Fax: (973) 972-4263

Elizabeth I. Lazo, MPH, PMP

Program Manager

[email protected]

Phone: (973) 972-9225

Judy Collins, BA

Marketing Coordinator

[email protected]

Phone: (973) 972-5528

Dominic Stanislaus, BA

Program Assistant

[email protected]

California

Resources: 42

Title Sort descending	Publish Date	Review Date
Assisting HIV Patients Returning to Mexico and Central America / Asistiendo a los Pacientes que Regresan a México y Centroamérica	10/01/2020
Barriers to Curing Hepatitis C Virus among Coinfected People with HIV Infographic	03/22/2017
Brand and Generic Names of ARVs in the United States and Mexico	06/20/2018
Community Health Worker Training Resources	04/15/2022
Conducting a Primary or Acute Care HIV Telemedicine Visit	06/09/2020
COVID-19 Resources for HIV Providers	03/20/2020	07/01/2021
COVID-19, HIV, and Housing Instability	12/29/2020
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates	06/10/2020
Evaluating AETC NCRC Partnerships for Impact	04/15/2019
Federal COVID-19 Resources	10/14/2020
Federal Training Centers Collaborative (FTCC) Virtual Learning Session Materials	03/25/2021
Flyer: Hepatitis C Screening and Treatment in People with HIV	06/29/2018	11/19/2019
Hep C Free Postcard	05/31/2018	11/29/2019
Hepatitis C: Getting Cured Is Easier than Ever	02/26/2019	12/02/2022
HHS Adult ART Guidelines: HIV and ART in Older People	01/31/2020
HHS Adult ART Guidelines: Initial Therapy	06/10/2021
HHS Adult ART Guidelines: Transgender People with HIV	01/31/2020
HHS Adult ART Guidelines: Treatment-Experienced Patients	06/10/2021
HIV & SARS-CoV-2 Webinar Series	12/07/2020
HIV Care Continuum: Key Resources for HIV Clinicians	12/14/2022
HIV Epidemic Rapid Response Toolkit	06/10/2019
HIV/HCV Co-infection: An AETC National Curriculum	07/13/2017	12/29/2019
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit	08/29/2022
Integrating Behavioral Health into Primary HIV Care — Covering the Bases	08/16/2021
Integrating Mental Health and Substance Use Care into HIV Primary Care Toolkit	06/02/2015	05/17/2019
Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)	11/27/2018	07/26/2021
New Pandemic, Old Inequities: Impacts of COVID-19 and HIV on Marginalized Populations	03/26/2021
Non-Occupational Post-Exposure Prophylaxis (nPEP) Toolkit	01/19/2022
Passport to Cure	03/09/2018	11/29/2019
Post COVID Syndrome: An Overview and Approach to Management	04/02/2021
Prescribing nPEP Infographic	01/22/2018	05/18/2021
Prescribing PrEP: A Guide for Healthcare Providers	01/11/2022
Quick Guide: CDC HIV Laboratory Testing Recommendations	02/01/2021
Rapid (Immediate) ART Initiation & Restart: Guide for Clinicians	05/19/2022
Reaching People with HIV in Rural United States	12/06/2021
Resources for Accessibility	07/30/2014	07/20/2018
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region	12/01/2020
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV	02/09/2021
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference	12/04/2022
Self-care, Resiliency, and Stress Management for Healthcare Providers	01/14/2021	05/18/2021
Tips for Managing Digital Design Projects	09/09/2022
U.S. Monkeypox (MPX) - Information and Recommendations	08/30/2022

Articles: 53

Title Sort descending	Publish date	Review date
AETC Representation at the 2022 National Ryan White Conference on HIV Care & Treatment	07/19/2022
Bictegravir Approved for Initial ART, in Combination with TAF/FTC	04/11/2018
Bictegravir in Initial Therapy	09/28/2017
Bictegravir/TAF/FTC in Women	04/11/2018
CROI 2017: Bictegravir and Dolutegravir, Head-to-Head Comparison	04/17/2017
CROI 2017: Dolutegravir in 2-Drug Simplification Studies	04/17/2017
CROI 2017: Doravirine Noninferior to Darunavir + Ritonavir in Initial Treatment	04/17/2017
CROI 2017: Failure of Dolutegravir Monotherapy	04/17/2017
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study	08/20/2018
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study	04/11/2018
Dolutegravir + 3TC in Initial Therapy	08/21/2018
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects	09/25/2018
Doravirine in Initial Therapy: DRIVE-AHEAD Study	10/03/2017
Doravirine--New NNRTI Approved by FDA	10/10/2018
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy	04/12/2016
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine	04/19/2019
HIV Care Tools – A New Resource for Ending the HIV Epidemic	05/12/2021
HIV Meds Update - RAPID: Immediate ART Initiation	09/27/2016
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA	09/27/2016
HIV Meds Update: PrEP Uptake by Sex, Race, and Age	09/27/2016
HIV Meds Update: Treatment as Prevention: Suppressive ART, Condomless Sex, and HIV Transmission Risk - also a Word on HPTN 052	09/27/2016
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine	10/18/2021	10/18/2021
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART	10/18/2021	10/18/2021
HIV Meds Updates: Long-acting Injectable Therapy: Lenacapavir	10/18/2021	10/18/2021
HIV-related Journal Articles by AETC-Affiliated Researchers and Faculty, 2019-2020	12/22/2020
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2021	02/21/2022
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2022	01/24/2023
Ibalizumab Approved for Persons with Multidrug Resistant HIV	04/11/2018
Immediate ART Initiation Improves Time to Viral Suppression	04/11/2018
Long-Acting Injectable ART: Cabotegravir + Rilpivirine	04/25/2019
Long-acting Injectable PrEP Approved: Cabotegravir	02/09/2022
Long-acting Injectable PrEP: Cabotegravir	09/20/2020
Naltrexone Improves Virologic Suppression	04/11/2018
NECA in the Know Special Edition Episode: All about Monkeypox	09/09/2022
New ARV Approval - Fostemsavir	09/04/2020
On the Way: The First Protease Inhibitor-Based Single-Tablet Regimen	09/28/2017
Possible Safety Issue with Dolutegravir during Pregnancy: Reports of Neural Tube Defects	05/23/2018
PrEP: Bone Density Improves after Stopping TDF/FTC	05/04/2016
PrEP: TDF/FTC vs TAF/FTC in MSM	04/25/2019
Rapid ART Start	10/16/2018
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)	04/11/2018
Safety of Dolutegravir at Conception: Updated Data	08/29/2020
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV	10/01/2015
Switching from TDF/FTC to TAF/FTC	03/18/2016
TargetHIV: New Name, New Look	09/12/2018
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women	09/25/2018
Tips for Successful Linkage to Care	02/04/2016
Tissue Levels of TAF: Too Low for PrEP?	03/17/2016
U=U in PARTNER2 Study of MSM	08/21/2018
Undetectable = Untransmittable: Effective HIV Treatment Prevents HIV Transmission	12/19/2017
Updated CDC PrEP Guidelines	02/09/2022
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy	09/25/2018
Use of Dolutegravir in Dialysis	05/04/2016

AETC NCRC Online

California

Resources: 42

Articles: 53